Compagno, Samuele; Casadio, Chiara; Galvani, Linda; Rosellini, Matteo; Marchetti, Andrea; Tassinari, Elisa; Piazza, Pietro; Mottaran, Angelo; Santoni, Matteo; Schiavina, Riccardo; Massari, Francesco; Mollica, Veronica, Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives, «JOURNAL OF CLINICAL MEDICINE», 2024, 13, Article number: 5738 , pp. 1 - 13 [Scientific article]Open Access
Massari, Francesco; Rosellini, Matteo; Mollica, Veronica, Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning, «NATURE REVIEWS. UROLOGY», 2024, 1, pp. 1 - 2 [Scientific article]
Mollica, Veronica; Rosellini, Matteo; Brocchi, Stefano; Galuppi, Francesco; Paccapelo, Alexandro; Tateo, Valentina; Marchetti, Andrea; Tassinari, Elisa; Mantuano, Francesco; Santoni, Matteo; Massari, Francesco, Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma, «EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT», 2024, 9, pp. 17 - 24 [Scientific article]Open Access
Tassinari, Elisa; Rosellini, Matteo; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco, What is the risk of hepatotoxicity induced by immune-checkpoint inhibitors and how can we avoid it?, «EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY», 2024, 1, pp. 1 - 4 [Scientific article]
Nuvola, Giacomo; Santoni, Matteo; Rizzo, Mimma; Rosellini, Matteo; Mollica, Veronica; Rizzo, Alessandro; Marchetti, Andrea; Battelli, Nicola; Massari, Francesco, Adapting to hormone-therapy resistance for adopting the right therapeutic strategy in advanced prostate cancer, «EXPERT REVIEW OF ANTICANCER THERAPY», 2023, 1, pp. 1 - 8 [Scientific article]
Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Tateo, Valentina; Nuvola, Giacomo; Rizzo, Alessandro; Massari, Francesco; Mollica, Veronica, An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma, «EXPERT OPINION ON DRUG SAFETY», 2023, 1, pp. 1 - 13 [Scientific article]
Santoni, Matteo; Rizzo, Alessandro; Kucharz, Jakub; Mollica, Veronica; Rosellini, Matteo; Marchetti, Andrea; Tassinari, Elisa; Monteiro, Fernando Sabino Marques; Soares, Andrey; Molina-Cerrillo, Javier; Grande, Enrique; Battelli, Nicola; Massari, Francesco, Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2023, 1, pp. 1 - 15 [Scientific article]
Conci, Nicole; Tassinari, Elisa; Tateo, Valentina; Rosellini, Matteo; Marchetti, Andrea; Ricci, Costantino; Chessa, Francesco; Santoni, Matteo; Grande, Enrique; Mollica, Veronica; Massari, Francesco, How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma?, «MOLECULAR DIAGNOSIS & THERAPY», 2023, 1, pp. 1 - 15 [Scientific article]
Rizzo, Alessandro; Mollica, Veronica; Tateo, Valentina; Tassinari, Elisa; Marchetti, Andrea; Rosellini, Matteo; De Luca, Raffaele; Santoni, Matteo; Massari, Francesco, Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2023, 1, pp. 1 - 14 [Scientific article]
Rizzo, Alessandro; Nuvola, Giacomo; Palmiotti, Gennaro; Ahcene-Djaballah, Selma; Mollica, Veronica; Rosellini, Matteo; Marchetti, Andrea; Nigro, Maria Concetta; Tassinari, Elisa; Macrini, Sveva; Massari, Francesco, Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysis, «IMMUNOTHERAPY», 2023, 1, pp. 1 - 10 [Scientific article]
Matteo Rosellini; Andrea Marchetti; Veronica Mollica; Alessandro Rizzo; Matteo Santoni; Francesco Massari, Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma, «NATURE REVIEWS. UROLOGY», 2023, 20, pp. 133 - 157 [Scientific article]Open Access
Marchetti, Andrea; Tassinari, Elisa; Rosellini, Matteo; Rizzo, Alessandro; Massari, Francesco; Mollica, Veronica, Prostate cancer and novel pharmacological treatment options - what's new for 2022?, «EXPERT REVIEW OF CLINICAL PHARMACOLOGY», 2023, 1, pp. 1 - 14 [Scientific article]
Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco, Re: Atezolizumab Plus Cabozantinib Versus Cabozantinib Monotherapy for Patients with Renal Cell Carcinoma After Progression with Previous Immune Checkpoint Inhibitor Treatment (CONTACT-03): A Multicentre, Randomised, Open-label, Phase 3 Trial, «EUROPEAN UROLOGY», 2023, 1, pp. 1 - 2 [Scientific article]
Mollica, Veronica; Tassinari, Elisa; Santoni, Matteo; Marchese, Paola Valeria; Giunchi, Francesca; Maloberti, Thais; Tateo, Valentina; Ricci, Costantino; Rosellini, Matteo; Marchetti, Andrea; Fiorentino, Michelangelo; Biase, Dario De; Massari, Francesco, TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab, «PATHOLOGY RESEARCH AND PRACTICE», 2023, 253, pp. 155008 - 155013 [Scientific article]
Mollica, Veronica; Rizzo, Alessandro; Marchetti, Andrea; Tateo, Valentina; Tassinari, Elisa; Rosellini, Matteo; Massafra, Raffaella; Santoni, Matteo; Massari, Francesco, The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study, «CLINICAL AND EXPERIMENTAL MEDICINE», 2023, 1, pp. 1 - 11 [Scientific article]
